Exposure and response prevention helps adults with obsessive compulsive disorder who do not respond to pharmacological augmentation strategies

OBJECTIVE: Serotonin reuptake inhibitors (SRIs) are a first-line treatment for obsessive-compulsive disorder (OCD). Yet, most OCD patients on SRIs do not show excellent response, and recent studies show that augmenting SRIs with risperidone benefits a minority of patients. We evaluated the effective...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Psychiatry
Hlavní autoři: McLean, Carmen P., Zandberg, Laurie J., Van Meter, Page E., Carpenter, Joseph K., Simpson, Helen Blair, Foa, Edna B.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135093/
https://ncbi.nlm.nih.gov/pubmed/26613263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.14m09513
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky